Concentrix (CNXC) Form 4/A Concentrix / Olivier Duha ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Duha Olivier

(Last) (First) (Middle)

39899 BALENTINE DRIVE

(Street)

NEWARK CA 94560

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Concentrix Corp [ CNXC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/27/2023

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Contingent Right to Common Stock	(1)(2)	09/25/2023		A		59,421		(2)	(2)	Common Stock	59,421	(2)	59,421	D
Contingent Right to Common Stock	(3)	09/25/2023		A		16,252		(3)	(3)	Common Stock	16,252	(3)	16,252	I	By Montana, a societe simple, organized under the Laws of Belgium
Contingent Right to Common Stock	(4)	09/25/2023		A		1,818		(4)	(4)	Common Stock	1,818	(4)	1,818	I	By Liberty Management, a societe a responsabilite limitee, organized under the laws of Belgium

Explanation of Responses:

1. On September 25, 2023, the Issuer completed its acquisition of the issued and outstanding capital stock of Marnix Lux SA, a public limited company (societe anonyme) organized under the Laws of the Grand Duchy of Luxembourg ("Marnix Lux"), the parent company of Webhelp, pursuant to the Share Purchase and Contribution Agreement dated June 12, 2023, as amended by the First Amendment to the Share Purchase and Contribution Agreement, dated July 14, 2023 by and among the Issuer, OSYRIS S.a.r.l., Marnix Lux and the holders of Marnix Lux (the "Transaction", and such agreement, as amended, the "Agreement").

2. Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 59,421 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.

3. Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 16,252 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.

4. Pursuant to, and subject to the terms and conditions in, the Agreement, the Reporting Person has the contingent right to receive up to 1,818 shares of common stock of the Issuer if the share price of the Issuer's common stock reaches $170.00 per share within seven years from September 25, 2023 (based on daily volume weighted average prices measured over a specific period), or if within three years from September 25, 2023 the Issuer has a change of control with per share consideration of at least $150.00.

Remarks:

This amendment supplements the Form 4 filed by the reporting person on September 27, 2023 to report the contingent rights described herein. The number of shares of common stock of the Issuer that may be issuable under these contingent rights is subject to the satisfaction of material contingencies in accordance with the terms of the Agreement but are reported herein for the avoidance of doubt.

	/s/ Andrew Farwig, Attorney-in-Fact	10/05/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.